Frazier Life Sciences X, L.P. - Apr 4, 2024 Form 4/A Insider Report for HilleVax, Inc. (HLVX)

Role: 10%+ Owner
Signature: FRAZIER LIFE SCIENCES X, L.P., By FHMLS X, L.P., its general partner, By FHMLS X, L.L.C., its general partner, By: /s/ Steve R. Bailey, Chief Financial Officer
Stock symbol: HLVX
Transactions as of: Apr 4, 2024
Transactions value $: $0
Form type: 4/A
Date filed: 5/31/2024, 04:57 PM
Date Of Original Report: Apr 8, 2024
Previous filing: May 3, 2022
Next filing: Sep 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HLVX	Common Stock						8.54M	Apr 4, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 8, 2024, the Reporting Persons filed a Form 4 which inadvertently reported the purchase of 8,850 shares of the Issuer's Common Stock by Frazier Life Sciences X, L.P. However, the stock purchase did not occur by Frazier Life Sciences X, L.P. but was purchased by other funds affiliated with Frazier Life Sciences X, L.P., as reported on the Schedule 13D amendment filed on the same day as this amendment, and as reported in this amendment, Frazier Life Sciences X, L.P. directly owned 8,535,337 shares of Common Stock of the Issuer as of April 8, 2024.
F2	The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X,, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper and Patrick J. Heron are the sole managing members of FHMLS X, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences X, L.P. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Content

On April 8, 2024, the Reporting Persons filed a Form 4 which inadvertently reported the purchase of 8,850 shares of the Issuer's Common Stock by Frazier Life Sciences X, L.P. However, the stock purchase did not occur by Frazier Life Sciences X, L.P. but was purchased by other funds affiliated with Frazier Life Sciences X, L.P., as reported on the Schedule 13D amendment filed on the same day as this amendment, and as reported in this amendment, Frazier Life Sciences X, L.P. directly owned 8,535,337 shares of Common Stock of the Issuer as of April 8, 2024.

The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X,, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper and Patrick J. Heron are the sole managing members of FHMLS X, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences X, L.P. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.